section name header

Pronunciation

SIM-va-sta-tin audio

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: 85% absorbed, but rapidly metabolized.

Distribution: Unknown.

Protein Binding: 95%.

Metabolism/Excretion: Extensively metabolized by the liver, most during first pass; excreted in bile and feces; 13% excreted unchanged by the kidneys.

Half-life: Unknown.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: amnesia, confusion, dizziness, headache, insomnia, memory loss, weakness.

GI: abdominal cramps, constipation, diarrhea, flatus, heartburn, altered taste, drug-induced hepatitis, dyspepsia, liver enzymes, nausea, pancreatitis.

GU: erectile dysfunction.

Derm: rashes, pruritus.

Endo: hyperglycemia.

MS: RHABDOMYOLYSIS, arthralgia, immune-mediated necrotizing myopathy, myopathy ( risk with 80 mg dose).

Misc: hypersensitivity reactions.

Interactions

Drug-Drug:

Drug-Food:

Route/Dosage

The 80 mg dose should be restricted to patients who have been taking this dose for ge.gif12 mo without evidence of muscle toxicity

Renal Impairment

Implementation

US Brand Names

FloLipid, Zocor

Classifications

Therapeutic Classification: lipid-lowering agents

Pharmacologic Classification: hmg coa reductase inhibitors (statin)

Availability

(Generic available)

Time/Action Profile

(cholesterol-lowering effect)

ROUTEONSETPEAKDURATION†
POdays2–4 wkunknown

†After discontinuation.

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Pill Image

simvastatin_195_9191.jpg

Code

NDC Code*